Intrinsiqq
SKAN Group AG logo

SKAN Group AG (SKAN.XSWX) DCF Valuation

Every assumption below is yours to change. The defaults are derived from this company's own filing history, not from a house view.

Conservative

CHF 8.07

89% overvaluedvs CHF 73.00

Growth 1–5Y%
Growth 6–10Y%
Terminal growth%
WACC%
Safety margin%

Base

CHF 9.30

87% overvaluedvs CHF 73.00

Growth 1–5Y%
Growth 6–10Y%
Terminal growth%
WACC%
Safety margin%

Optimistic

CHF 10.65

85% overvaluedvs CHF 73.00

Growth 1–5Y%
Growth 6–10Y%
Terminal growth%
WACC%
Safety margin%

Where today's price sits

Today CHF 73.00
Conservative CHF 8.07
Base CHF 9.30
Optimistic CHF 10.65

Today's price falls outside the modelled range.

Verdict

Today's price sits above all three scenarios. Under these assumptions the stock looks overvalued, so either the growth inputs are too conservative or the price is ahead of the cash flows.

Base free cash flow

CHF 18M

Trailing twelve months

Historical FCF CAGR

-13.5%

Across 6 reported periods

Market implies

30.6%

Growth needed at 8% WACC

Terminal value share

58%

Of the base case valuation

Growth needed to justify today's price

At a 8.0% discount rate, today's price already assumes 30.6% annual free cash flow growth for ten years. Your base case assumes 2.0%, so the market is paying for growth you are not forecasting.

Curve holds terminal growth at 2.5%, years 6 to 10 at half the first-stage rate, and applies no safety margin.

Free cash flow history

The most recent period is the base every projection starts from. Compounded, that history is -13.5% a year.

Source: company annual reportsLast synced Jun 22, 2026Base FCF CHF 18M (TTM)

A DCF output is an assumption-sensitive range, not a price target. This model is an algorithmic estimate from your inputs and company filings, and it is not a recommendation to buy, sell or hold. Terms · Methodology

SKAN Group (SKAN.XSWX) DCF: intrinsic value and margin of safety

Intrinsiqq's two-stage DCF values SKAN Group (SKAN.XSWX) at about CHF 12.40 per share, or CHF 9.30 with a 25% margin of safety. At CHF 73.00 the stock looks overvalued. Every assumption is adjustable below; this is analysis, not investment advice.

Frequently asked

What is SKAN Group's (SKAN.XSWX) fair value?+

Intrinsiqq's two-stage discounted cash flow (DCF) model estimates an intrinsic value of about CHF 12.40 per share for SKAN.XSWX. It projects recent free cash flow forward at a growth rate that fades toward a long-run rate, then discounts those cash flows back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around CHF 9.30. The output moves with the growth and discount-rate inputs, so it is best read as a range, not a single number. You can change every assumption with the sliders on this tab.

Is SKAN Group overvalued based on a DCF?+

At CHF 73.00, SKAN.XSWX trades above the base-case intrinsic value of about CHF 12.40, a 83.0% premium over that estimate, so on this model it looks overvalued. A DCF is only one lens: a premium can be justified if the business grows faster or is higher quality than the base case assumes, which is exactly what the sliders let you test.

What growth is priced into SKAN Group?+

The base case grows SKAN.XSWX's free cash flow at about 2.0% a year before fading, against roughly -13.5% historical free-cash-flow growth. If the price implies growth well above what the company has actually delivered, the market is paying for optimism; if below, expectations are modest. Adjust the growth assumption on this tab to see what the current price is really betting on.

What is a good margin of safety for SKAN Group?+

A margin of safety is the discount to intrinsic value you demand before buying, to protect against being wrong on the inputs. Intrinsiqq applies 25% by default, which turns SKAN.XSWX's CHF 12.40 intrinsic estimate into a CHF 9.30 entry. Wider margins suit less predictable businesses; you can set your own on this tab. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Related stocks: Medical Instruments & Supplies

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.